AI assistant
Biohit Oyj — Director's Dealing 2017
Mar 3, 2017
3304_dirs_2017-03-03_d8683779-d750-477c-a913-a4dda5a61227.html
Director's Dealing
Open in viewerOpens in your device viewer
Disclosure 349770
Biohit Oyj - Managers' transactions
Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:00 am local time (EET) Person subject to the notification requirement Name: Korpela, Semi Position: Chief Executive Officer ---------------------------------------------------------------------- Initial Notification Reference number: 74370089ATTSNBXJVT29_20170302113238_1 ---------------------------------------------------------------------- Issuer Name: Biohit Oyj LEI: 74370089ATTSNBXJVT29 ---------------------------------------------------------------------- Transaction details Transaction date: 2017-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Acquisition Instrument: Share ISIN: FI0009005482 Volume: 1240 Unit price: 5,29000 Euro Aggregated transactions Volume: 1240 Volume weighted average price: 5.29000 Euro Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com